MolecuLight to Exhibit and Showcase New Consensus on Fluorescence Imaging in Surgical Wound Management at IPAWS Summit 2025

November 13, 2025 -

Pittsburgh, USA – November 13, 2025 – MolecuLight Corp., a global leader in point-of-care fluorescence imaging for wound assessment, is proud to announce the publication of a landmark international consensus report, developed by leading experts in wound care and surgery from across the United States. The report,

Large Independent Randomized Controlled Trial Validates MolecuLight’s Transformative Impact on Wound Debridement, Showing Improved Outcomes and Lower Costs

August 27, 2025 -

PITTSBURGH, USA and TAIPEI, TAIWAN, August 27, 2025 – MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for wound care, together with its Taiwanese distributor, Healtdeva Company Ltd., today announced the publication of the largest-ever randomized controlled trial (RCT) on its technology. Independently conducted and published

MolecuLight “Lights the Way to Equitable Wound Care” at National Medical Association Conference

July 18, 2025 -

Pittsburgh, USA – July 18, 2025 – MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for wound care, today announced its participation in the National Medical Association (NMA) Annual Convention and Scientific Assembly, being held from July 19-23, 2025, in Chicago, IL. Attendees are invited to

MolecuLight Appoints Dr. Julia Wright as Chief Medical Officer to Accelerate Clinical Adoption

July 10, 2025 -

Pittsburgh, USA – July 10, 2025 – MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for wound care, today announced the appointment of Dr. Julia Wright, MD, FACP, as its new Chief Medical Officer (CMO). Dr. Wright, an exceptionally respected physician with a distinguished 25-year career

Landmark Study Affirms MolecuLight’s Efficacy in Real-Time Bacterial Detection for Improved Wound Management

June 26, 2025 -

Pittsburgh, USA – June 26, 2025 – MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for wound care, proudly announces the publication of a landmark systematic review by researchers at Trinity College Dublin and the Royal College of Surgeons in Ireland (RCSI). Titled “The Clinical Utility

MolecuLight Showcases Innovative Multimodal Imaging with Thermal Capabilities at St. Louis Wound & Vascular Symposium

June 21, 2025 -

Pittsburgh, USA – June 21, 2025 – MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for wound care, is proud to showcase its presence at the St. Louis Wound & Vascular Symposium, being held today, Saturday, June 21, 2025, in St. Louis, MO. Attendees are invited to experience firsthand

MolecuLight® Imaging Significantly Improves Outcomes and Cuts Costs for Deep Sternal Wound Infections in Taiwan Study; Signals Expansion into Surgical Applications

June 12, 2025 -

Pittsburgh, USA and Taipei, TAIWAN – June 12, 2025 – MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for wound care, and its Taiwanese distributor, Healtdeva Company Ltd., congratulate researchers at Shuang-Ho Hospital in Taipei, Taiwan on their publication of groundbreaking findings using MolecuLight. The clinical study

MolecuLight to Showcase Innovative Wound Imaging Platform at the Society for Vascular Surgery Vascular Annual Meeting (VAM) 2025

June 4, 2025 -

Pittsburgh, USA – June 4, 2025 – MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, is pleased to announce its participation in the Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM), taking place in New Orleans,

MolecuLight and DocNow Announce Integration for Seamless Data and Image Transfer for DX Devices

April 29, 2025 -

Toronto, Canada – April 29, 2025 – MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, and DocNow, an innovative post-acute Electronic Health Record (EHR) platform, today announced their integration for the MolecuLightDX™ device.

This powerful collaboration will